Grove Bank & Trust Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG

Grove Bank & Trust raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 129.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,936 shares of the medical equipment provider’s stock after purchasing an additional 1,656 shares during the quarter. Grove Bank & Trust’s holdings in Intuitive Surgical were worth $1,663,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Holos Integrated Wealth LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $25,000. Kilter Group LLC bought a new stake in Intuitive Surgical during the second quarter valued at approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $27,000. Caitlin John LLC purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $30,000. Finally, KERR FINANCIAL PLANNING Corp bought a new position in Intuitive Surgical in the third quarter worth approximately $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ISRG. BTIG Research reiterated a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research note on Friday, January 23rd. Raymond James Financial upped their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Royal Bank Of Canada raised their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Sanford C. Bernstein boosted their price target on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Finally, UBS Group reduced their price target on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical Price Performance

ISRG opened at $477.76 on Friday. The company has a 50 day simple moving average of $502.83 and a two-hundred day simple moving average of $512.95. The firm has a market cap of $169.67 billion, a P/E ratio of 60.55, a PEG ratio of 3.69 and a beta of 1.66. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.21 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 645 shares of the business’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the transaction, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. The trade was a 28.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 32,943 shares of company stock valued at $17,279,568 in the last ninety days. Insiders own 0.70% of the company’s stock.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Fundamentals remain strong — Intuitive reported an earnings beat and double‑digit revenue growth in its latest quarter, supporting the company’s long‑term growth thesis and valuation premium. Bull of the Day: Intuitive Surgical (ISRG)
• Positive Sentiment: Prominent bullish mentions — coverage including a “Bull of the Day” piece and a Jim Cramer mention keep ISRG on the buy/hold radar for growth investors, which can support buying interest after negative headlines. Jim Cramer Analyzed 5 Stocks
• Neutral Sentiment: Comparative analyses and sector commentary (head‑to‑head pieces) provide context but no immediate catalyst; these may influence longer‑term positioning rather than intraday moves. Head‑To‑Head Analysis: Lombard Medical & Intuitive Surgical
• Negative Sentiment: FDA safety flag on stapler devices — regulators have flagged safety concerns and advised halting affected devices, which is a near‑term operational and reputational risk that likely pressured the stock. FDA Flags Safety Concern Over Intuitive Surgical Stapler
• Negative Sentiment: Company warning and reported death related to stapler reloads — Intuitive issued warnings after at least one reported death, increasing legal, recall and adoption‑risk concerns for affected products. Intuitive warns on surgical stapler reloads with one death reported
• Negative Sentiment: Broader quality and cybersecurity scrutiny — reporting highlights recalls and other operational snags (including cyber incidents), which amplify investor uncertainty about near‑term execution and regulatory exposure. From Cyber Criminals to Recalls: Inside Intuitive Surgical’s Newest Snag
• Negative Sentiment: Technical weakness — the stock recently formed a “death cross” (50‑day moving average crossing below the 200‑day), which can trigger momentum selling from technical traders even if fundamentals remain solid. Intuitive Surgical Stock Just Flashed A Death Cross

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.